Posted on August 23, 2007 by BioJobBlogger

FDA Approves ImClone's New Biomanufacturing Plant-More Manufacturing Jobs for New Jersey

ImClone Systems Incorporated (NASDAQ: IMCL) announced today that is has received approval from the Food and Drug Administration for a second facility to manufacture ERBITUX®. Company officials said that “The approval to manufacture ERBITUX in this new 250,000-square-foot multi-suite manufacturing facility, referred to as "BB50", more than doubles ImClone's total available production volume capacity for ERBITUX. This approval, in conjunction with ImClone's existing "BB36" manufacturing facility, enhances the Company's ability to meet increasing demand for ERBITUX in the worldwide market”.

Approval of the new facility, located in Branchburg, NJ could translate into additional jobs to an already battered manufacturing workforce.

If you live in NJ, and have biomanufacturing experience dust off that resume and shoot it over to the folks at ImClone.

Until next time….

Good Luck and Good Job Hunting!!!!!!!!!!!

Visit DiversityJobs.com for information on Diversity in the workplace
Tags:
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.biojobblog.com/admin/trackback/38620
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.